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ABSTRACT
OBJECTIVE: To evaluate the clinical factors, as well as weight gain, in a group of pregnant 
women, associating them with fetal macrosomia in a public institution in Antioquia, Colombia, 
from 2010-2017. 
METHODS: A case-control study, using secondary information registries. Cases were defined 
using newborn weight of ≥ 4000g, while controls were defined as newborn weight between 3000–
3999g.  A proportion ratio (PR) was established to evaluate factors associated with macrosomia, 
and a generalized linear model (GLM) of Poisson regression with robust variance was used to 
evaluate the aspects that best explained macrosomia in the neonate.
RESULTS: 122 pregnant women participated in the study, of which 611 were cases and 61 
were controls.  Of the participants, 44.3% had pre-pregnancy overweight and 48.4% had excess 
gestational weight gain.  Statistically significant differences were found between the groups 
in the following variables: pre-pregnancy BMI (p = 0.004), gestational weight gain (p = 0.000), 
gestational diabetes (p = 0.000), and type of delivery (p = 0.004).  According to the regression 
model, a macrosomic newborn is 3.5 times more likely in women with excessive gestational weight 
gain (95%CI 1.78-7.18) and twice more likely in women who have gestational diabetes (95%CI 
1.51-2.76).  Of women with pre-pregnancy excess weight, 63% had excess gestational weight gain.
CONCLUSIONS: Within this cohort, pre-pregnancy BMI, excess weight gain in pregnancy, 
and the presence of gestational diabetes were associated with an increased risk of neonatal 
macrosomia. pre-pregnancy BMI and weight gain in pregnancy are modifiable risk factors that 
are responsive to nutrition interventions, which can minimize adverse perinatal outcomes.
DESCRIPTORS: Fetal Macrosomia. Risk Factors. Birth Weight. Body Weight Gain. Prenatal 
Nutritional Physiological Phenomena. Maternal and Child Health.
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INTRODUCTION
The figures of excess weight have had an increase in the world population in recent decades. 
Report of the Panorama of Food and Nutrition Security in Latin America and the Caribbean 
has shown that overweight and obesity, in more than 20 countries on the continent, was 
10 percentage points higher in women than in men in 20161. A report prepared in 2015 by 
the United Nations states that one in four women in adulthood is obese2. The situation is 
no different in Colombia: the prevalence of overweight and obesity in the adult population 
is 55.2% in women compared with 45.6% in men3. 
More and more women begin pregnancy in excess weight. The 2015 National Survey of 
Nutrition Situation in Colombia indicates that 39.9% of pregnant women of all age groups 
were overweight (24.7% overweight and 15.2% obese) in the country3. Other observational 
studies in representative samples of pregnant women in countries such as Peru4, Brazil5, 
and Uruguay6 show overweight prevalence of 63.8%, 47.5% and 32.6%, respectively.  
This scenario directly affects birth weight. A study in 23 countries showed a prevalence of 
macrosomia of 4.5% and 5.4% in Latin America. In developed countries, it ranged between 
5% and 20%, and a 15-25% increase has been reported in the last three decades7. In Colombia, 
an investigation was conducted based on the Live Birth Registry of the Administrative 
Department of Vital Statistics from 2002 to 2011, among which about 6,000,000 births 
were registered. Low birth weight amounted to 3.8%, while macrosomia reached 4.5% in 
full-term newborns (NB) 8. 
The excess weight-gestation binomial can mark the origin of a range of diseases. Various 
mechanisms seem to come together in the metabolic programming and generational transfer 
of obesity and its associated comorbidities: inflammation, oxidative stress, neurohormonal 
disorders, epigenetic modifications, quality of the maternal microbiota, macrosomia and 
greater fetal adiposity9; in addition to greater admission to the neonatal intensive care unit, 
respiratory disturbances and neonatal death10.
Risks of excess weight in the mother include preeclampsia, venous thromboembolism, 
hypertension, gestational diabetes, postpartum hemorrhage and a greater chance of assisted 
vaginal delivery or caesarean section10. An analytical study conducted with more than 
3,000 mothers in Buga, Colombia, between 2005 and 2015, showed correlations between 
maternal obesity, preeclampsia, eclampsia and gestational diabetes. Children of mothers 
with gestational diabetes and obesity were significantly heavier at birth11. 
There are few studies focused on macrosomia at the national level. Scientific evidence has 
focused on obstetric complications and the study of maternal-fetal metabolic disorders. 
In addition, the risk analysis of public health events in NBs has focused on low birthweight12. 
However, the increased numbers of female obesity and macrosomia support the need for 
this to be considered an important indicator in prenatal care and surveillance due to its 
deleterious effects in the short, medium, and long term in the health of the newborn.
The purpose of this research was to analyze clinical factors and weight gain in pregnant 
women and their association with fetal macrosomia. 
METHODS 
Analytical case-control study, nested in a defined cohort of NB in a second level 
institution responsible for the health care of the southwestern department of Antioquia 
between 2010–2017, and their mothers, who performed prenatal control in the same 
institution or in others from nearby municipalities. Information sources were the birth 
record, the Latin American Center for Perinatology (CLAP) record, and the maternal 
medical history. 
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Selection criteria were: mothers between 15 and 45 years old; prenatal control carried 
out in the institution or institutions of nearby municipalities; minimum 90% of the 
data in the CLAP file or clinical history; data on pre-pregnancy weight, or measured 
before week 14, one ≥ at week 36, and anthropometric data of the newborn. Mothers 
with multiple pregnancies, pre-pregnancy diabetes and NB with congenital diseases 
were excluded. Macrosomic NBs weighing ≥ 4,000 g were identified, as specific inclusion 
criteria for the study case group. The same inclusion criteria were applied for the control 
group, except for birth weight, which was defined as a weight between 3,000 and 3,999 g, 
considered adequate. 
From the census population of NB in the institution, 300 macrosomic infants were obtained, 
of which 61 met the selection criteria. Pairing of cases and controls 1:1 was performed 
(Figure 1). The following sociodemographic variables were considered according to their 
hierarchy: maternal age, previous pregnancies, socioeconomic level, NB year of birth, and 
municipality of origin. Both cases and controls had a median age of 24 years and a previous 
pregnancy, with prevalence of low socioeconomic levels and secondary/university education, 
which indicated there were no significant differences between them (p> 0.005). Marital 
status and educational level were considered as non-mandatory matching variables; the 
total sample was 61 cases and 61 controls. 
Aspects such as pre-pregnancy body mass index (BMI), weight gain and pathologies during 
pregnancy were studied. In the neonate, data on sex, weight, length, head circumference and 
gestational age at birth were collected, which were classified according to data reported in 
the medical history, date of the last menstruation or first trimester ultrasound. 
For the analysis plan, the classification of the pregnant women nutritional status according 
to age was considered, according to 2016 Resolution no. 2465 by the Ministry of Health and 
Social Protection of the Republic of Colombia13. pre-pregnancy BMI in pregnant women 
under the age of 19 was performed using the BMI indicator for age; for those over 19 years 
old, classification was made according to the BMI indicator for gestational age, based on the 
standard proposed by Atalah et al.14: underweight below 20 kg/m2, normal 20–24.9 kg/m2, 
overweight 25–29.9 kg/m2, and obesity ≥ 30 kg/m2. Both standards are accepted by the 
national standard. 
Figure 1. Procedure for obtaining the sample. 
Census population
of newborns 
ESE Hospital San Vicente
de Paul, Caldas Antioquia
from 2010 to 2017 300 macrosomic
infants
After the revision of inclusion and 
exlusion criteria of the study
61 macrosomic infants
participating (Cases)
According to the municipality in which 
the mother carried out her prenatal control
Caldas: 13 Amagá: 13 Andes: 13 Others: 11 
Matching criteria: mother’s age, prior 
pregnancies, newborn birth year, 
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The weight gain goal was calculated according to the healthy pre-pregnancy weight, 
equivalent to a BMI of 22.5 kg/m2. Weight gain in adults was classified as follows: 
underweight 12-18 kg, adequate weight 10–13 kg, overweight 7–10 kg, and obesity 6–7 kg15. 
In adolescents, it was classified as: underweight between 12–20 kg, adequate weight between 
12.5–17 kg, overweight between 7.5–12.5 kg and, in obese women, less than 7kg16. Inadequate 
gain due to deficit was defined as lower than the recommended weight ranges; excessive 
weight gain was related to that which exceeded the recommendation, and adequate gain 
remained within the specified ranges. 
For the classification of total weight gain, the difference between the last pre-delivery 
weight recorded in week 36 or later weeks and the pre-pregnancy weight recorded at week 
14 or less was calculated. If the birth occurred after the week in which the last weight of 
the mother was recorded, weight gain was projected according to the percentile of gain of 
each pregnant woman. Maternal height greater than 1.55 m was considered as a cut-off 
point for the risk of macrosomia at birth, according to previous studies17. 
A systematized instrument was developed in the Epi Info program, version 7.2.1.0, for 
the collection of information. Collection was carried out by previously trained and 
standardized personnel. Descriptive analysis included absolute and relative distributions, 
as well as summary indicators such as arithmetic mean, standard deviation, quartiles 
and interquartile range. The normality criterion for some sociodemographic and clinical 
variables was established by the Shapiro Wilk test. U-Mann Whitney test or Student t-test 
for independent samples were used to determine the relationship between macrosomia 
and some quantifiable sociodemographic and clinical aspects. The relationship between 
sociodemographic aspects and clinical history with macrosomia was defined by Pearson’s 
chi-square test or Fisher’s exact test. Strength of association was evaluated by proportion 
ratio (PR), with its respective 95% confidence intervals (95%CI) (p < 0.05).
A parsimonious model was applied, which selected the variables that best explained the 
effect of macrosomia by a generalized linear model (GML) of Poisson regression with robust 
variance. Statistical data processing was performed in SPSS Software, version 23. 
The research was approved by the ethics committee of the Faculty of Nursing of the 
University of Antioquia. Institutions in which the data collection process was carried out 
gave their endorsement and authorization for the review of data sources. The study was 
considered an “investigation with minimal risk”, with strict custody and confidentiality 
of information, in accordance with Statutory Law 1581, of 2012, and Resolution number 
1995, of 1999.
RESULTS 
In both groups, the median age was 24 years old and 75.4% of the participants were between 
19 and 34 years old; the predominant educational level (81.1%) was secondary-university; 
74.6% had low socioeconomic status; 82% were affiliated with the subsidized health regime, 
and 68% had the presence of a partner (married or in free union). 
Of the mothers, 59.8% were multiparous, 18.0% had previous abortions, and 78.7% performed 
six or more prenatal controls. They presented a family history of 50% arterial hypertension, 
and 26.2% of diabetes mellitus. Prior preeclampsia was 6.2% and, during pregnancy, 2.5%. 
The threat of preterm birth reached 27.8% and premature rupture of membranes, 5.7%. 
The average gestational age at birth of the NB was 39 weeks in both groups, with an average 
birth weight in the case group of 4120 grams, and of 3334 grams in the control group. Mean 
length at birth was 52.3 cm and 50 cm in the case and control groups, respectively. The mean 
head circumference in the cases was 36 and, in the controls, 34.5 cm. The predominant sex 
in the NB was male, with 60.7%, compared with 39.3% of females, with a similar distribution 
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among the groups. Regarding the type of delivery, 63% of macrosomic NBs were born by 
caesarean section. 
The median pre-pregnancy weight of pregnant women was 60.7 Kg; 65.1 kg in the case group 
and 57.8 kg in control. The average height was 1.57 m. The median pre-pregnancy BMI in 
the studied sample was 26.6 kg/m2, and 23.2 kg/m2 in the control group. Average weight 
at the end of pregnancy 78.5 kg and 68.8 kg in the case and control groups, respectively. 
Half of the mothers started gestation with adequate weight; 28.7% overweight, 15.6% with 
obesity, and 5.7% underweight. The average weight gain was 12.2 kg. 
Of the pregnant women who presented excess pre-pregnancy BMI, 64.8% had macrosomic 
children, while in pregnant women with adequate BMI the percentage was 38.2%. 
Macrosomia was 1.6 times more likely in pregnant women with excess pre-pregnancy BMI 
compared with those who did not (95%CI 1.18-2.43; p = 0.004). 63.9% were > 1.55 m tall; 
however, no statistical differences were found between the groups regarding this variable 
(p = 0.131) (Table 1).
In pregnant women with excessive weight gain, 71.2% presented macrosomic NB. The risk 
of macrosomia increased 3.6 times in pregnant women who had excessive weight gain, 
compared with those who had adequate or poor gain (95%CI 1.59–7.95; p = 0.002) (Table 1).











< 19 * 19 (15.6) 8 (42.1) 11 (57.9)
19 to 34 92 (75.4) 47 (51.1) 45 (48.9) 0.674
1.21
(0.68–2.13)




Presents prior pregnancies 73 (59.8) 37 (50.7) 36 (49.3)
0.853
1.03
(0.72–1.49)Does not present prior pregnancies 49 (40.2) 24 (49.0) 25 (51.0)
Socioeconomic level
Low 91 (74.6) 45 (49.5) 46 (50.5)
0.835
0.96
(0.64–1.43)Medium-High 31 (25.4) 16 (51.6) 15 (48.4)
Education level
None-Primary 23 (18.9) 11 (47.8) 12 (52.2)
0.817
1.06
(0.66–1.69)Secondary-University 99 (81.1) 50 (50.5) 49 (49.5)
Maritial Status
Absence of partner 39 (32) 19 (48.7) 20 (51.3)
0.846
1.04
(0.71–1.53)Presence of a partner 83 (68) 42 (50.6) 41 (49.4)
Mother height 
Risk height 78 (63.9) 18 (40.9) 26 (59.1)
0.131
1.35
(0.89–2.03)No-risk height 44 (36.1) 43 (55.1) 35 (44.9)
pre-pregnancy body mass 
index
Excess weight 54 (44.3) 35 (64.8) 19 (35.2)
0.004
1.69
(1.18–2.43)No excess weight 68 (55.7) 26 (38.2) 42 (61.8)
Body Weight Gain
Inadequate due to deficit * 25 (20.5) 5 (20.0) 20 (80.0)
Adequate 38 (31.1) 14 (36.8) 24 (63.2) 0.179
1.84
(0.76–4.49)




Subsidized/Associate 100 (82) 46 (46.0) 54 (54.0)
0.031
0.67
(0.47–0.96)Contributory 22 (18) 15 (68.2) 7 (31.8)
Diabetes in pregnancy
Present 18 (14.2) 16 (88.9) 2 (11.1)
0.000
2.05
(1.56–2.71)Not present 104 (85.2) 45 (43.3) 59 (56.7)
Childbirth type
Caesarean section 62 (50.8) 39 (62.9) 23 (37.1)
0.004
1.72
(1.17–2.52)Spontaneous 60 (49.2) 22 (36.7) 38 (63.3)
Total of prenatal controls
Less than 6 controls 26 (21.3) 15 (57.7) 11 (42.3)
0.377
1.20
(0.81–1.78)6 or more controls 96 (78.7) 46 (47.9) 50 (52.1)
PR: proportion ratio
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Of women with excess pre-pregnancy weight, 63% had excessive weight gain and 24.1% had 
adequate weight gain; statistically significant differences were found between pre-pregnancy 
BMI and weight gain classification (Figure 2). 
Of the pregnant women with gestational diabetes, 88.9% had macrosomic children. 
Macrosomia was 43.3% in those who did not have diabetes. The risk of macrosomia was 
twice as high in pregnant women with gestational diabetes, compared with those who did 
not present it (95%CI 1.56–2.71; p = 0.0001) 
Of the participants with excess pre-pregnancy weight (n = 54), 31.5% had diabetes; of those 
who did not present pre-pregnancy excess weight (n = 68), 1.5% presented it; statistically 
significant differences were found between pre-pregnancy BMI and the presence of diabetes 
in the mother (p <0.00001). Weight gain showed no association with gestational diabetes 
(Figure 2).
The variables that best explained macrosomia were gestational weight gain and 
gestational diabetes in the final multiple regression model. The probability of being 
Figure 2. A. Pre-pregnancy Body Mass Index vs Gestational weight gain B. Gestational weight gain vs 
Gestational diabetes C. Pre-pregnancy Body Mass Index vs Gestational diabetes. 
With excess pre-pregnancy weight 
No excess pre-pregnancy weight 
With excess pre-pregnancy weight 
No excess pre-pregnancy weight 
With gestational diabetes 
Without gestational diabetes
p = 0.941
p = 0.014 p < 0.0001
Gestational weight gain
vs Gestational diabetes
Pre-pregnancy Body Mass Index
vs Gestational diabetes
Pre-pregnancy Body Mass Index
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macrosomic increased 3.5 times in pregnant women with excessive weight gain (95%CI 
1.78–7.18) compared with pregnant women with adequate or insufficient weight gain. 
Likewise, pregnant women with gestational diabetes (95%CI 1.51–2.76) were twice 
as likely to have a macrosomic child, compared with those who did not develop this 
disease (Table 2). 
DISCUSSION
Maternal factors such as excess pre-pregnancy weight, excessive weight gain, and diabetes 
during pregnancy increase the likelihood of macrosomia in the newborn. Overweight and 
obesity at the start of pregnancy were risk factors for excessive weight gain and the onset 
of gestational diabetes. 
Excess weight changes the intrauterine environment and leads to a higher risk of obstetric 
and neonatal complications. In this study, almost half of the pregnant women were 
overweight or obesity before pregnancy. This is in line with results of the 2015 National 
Survey of Nutrition Situation in Colombia3, which found that 39.9% of them presented 
excess weight. 
The relationship between excess pre-pregnancy weight and newborn macrosomia has been 
evidenced, which are conditions associated with an increased risk of perinatal mortality 
and neonatal morbidity. In an investigation conducted by Koyanagi et al. in 23 countries, he 
concluded that excess pre-pregnancy BMI is associated with a birth weight > 4000 g7. Other 
studies conducted in countries such as Cameroon18, the USA19, Lebanon20, Uruguay6, Peru17, 
Argentina21 and Paraguay22 showed an association between excess pre-pregnancy weight 
and macrosomia, similarly to this study. Excess pre-pregnancy weight has contributed to 
the increased prevalence of macrosomia in different countries, in some cases, regardless 
of weight gain in pregnancy7. The evidence of a relationship between BMI and effects on 
birthweight is overwhelming23.
Pregnant women with excess pre-pregnancy weight exceeded the gain recommendations 
in this study. Multiple investigations in different countries coincide with these findings 
and state that pre-pregnancy overweight or obesity imply a greater possibility of 
exceeding the recommended weight gains, which aggravates the prospect for this group 
of pregnant women2,20,23,24. 
Excessive gestational weight gain was the variable with the greatest effect on the 
probability of a newborn with macrosomia, according to the findings of this investigation. 
Other authors have reported similar results and state that obese and overweight women 
had higher proportions of total weight gain23, 25, 26. This can generate a fetus of greater 
birthweight, even in women without pre-pregnancy excess weight6,22. An expert review 
published in 2016 shows that women were more likely to have macrosomia when they had 
excessive BMI variations. This shows the need to carry out a strict monitoring of weight 
gain, especially in those women with pre-pregnancy excess. They require a differentiated 
attention that contributes to achieving a gain adjusted to their pre-pregnancy weight27. 
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Another aspect associated with the appearance of macrosomia was gestational diabetes 
mellitus. Hyperglycemia states are linearly associated with the increase in newborn 
weight28. Additionally, the prevalence of diabetes is higher in pregnant women with 
excess weight, compared with pregnant women with normal BMI, and grows as the 
BMI increases. Women with BMI > 25 are up to six times more likely to develop it 
and have a higher risk of simultaneous diagnoses of gestational hypertension and 
post-gestational diabetes10,11.
Macrosomia occurred in a greater proportion in infants of young mothers, with a secondary 
or university education level, with one or without previous pregnancies, and with a low 
proportion of gestational diabetes. The maternal variables associated with newborn 
macrosomia are age > 35 years old, low educational level, greater number of children, few 
prenatal controls, and pre-pregnancy diabetes or that develops during pregnancy9,29,30. This 
study indicates that pre-pregnancy excess weight and excessive weight gain have a marked 
effect on the onset of macrosomia, which is independent of other variables. 
To restrain the spread of epidemic excess weight, women must receive a comprehensive 
intervention before, during, and after pregnancy. Within the strategies to improve sexual 
and reproductive health in Colombia, establishing a guide or protocol containing guidelines 
addressed to decision-makers, public health policymakers, health care institutions, and 
interprofessional groups at all levels of attention is a priority. These guidelines should be 
geared towards the prevention and timely intervention of excess weight in women, as well 
as the prevention of excessive gestational weight gain in pregnant women, regardless of 
their pre-pregnancy BMI. This may contribute to the reduction of fetal macrosomia as one 
of its associated complications. 
Prenatal control programs and professionals responsible for the care of pregnant woman 
are called to take the lead in this matter. A differential and contextualized care must be 
devised. Interventions for pregnant women with excess weight should include: education 
and nutritional care, physical activity according to maternal health, empowerment 
of women around their prenatal care and, especially, their weight gain and dietary 
interventions4–6,23,24. Interventions should contribute to weight gains adjusted to the 
pre-pregnancy BMI and motivate mothers to improve the selection, portion size and 
preparation of foods with low caloric density and higher nutritional value, favoring the 
prevention of micro-nutrients deficit risk and the management of anxiety face food, 
to achieve the proposed goals. 
A limitation of this study is the collection of data from secondary sources, which may 
affect their quality. pre-pregnancy BMI and weight gain in pregnancy are modifiable risk 
factors that are susceptible to nutritional intervention and can contribute to minimizing 
adverse perinatal outcomes. This analysis contributes to the discussion about maternal 
excess weight and macrosomia in newborns, as aspects of paramount importance given 
the weight gain in women of childbearing age worldwide, and the deleterious effects of 
macrosomia in the short-, medium-, and long-term health. The results of this study are of 
great relevance for the department of Antioquia and the rest of the country, and they are 
expected to be taken as input at the national level to declare macrosomia at birth as an 
indicator of public health.
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